SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-353898
Filing Date
2018-12-20
Accepted
2018-12-20 08:06:33
Documents
3
Period of Report
2018-12-19
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d679244d8k.htm 8-K 18774
2 EX-99.1 d679244dex991.htm EX-99.1 11886
3 GRAPHIC g679244g1220090525132.jpg GRAPHIC 3600
  Complete submission text file 0001193125-18-353898.txt   37015
Mailing Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080 650.515.3185
CytomX Therapeutics, Inc. (Filer) CIK: 0001501989 (see all company filings)

IRS No.: 273521219 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37587 | Film No.: 181244676
SIC: 2834 Pharmaceutical Preparations